Where is UTEST's headquarters located?

UTEST's headquarters is located in Toronto (Canada).

How many companies has UTEST invested in?

UTEST has invested in 112 companies, including ODAIA & Deep Genomics.

Which companies has UTEST invested in lately?

YScope & QurCan Therapeutics are the latest investments by UTEST.

How many exits has UTEST been involved in?

UTEST's portfolio has seen 6 acquisitions.

UTEST - 2026 Investor Profile, Portfolio, Team & Investment Trends

1. ODAIA

Provider of AI-powered intelligence platform for pharmaceutical commercial and sales teams. The platform delivers relevant targets, prioritized call lists, and personalized insights. It helps sales representatives engage with healthcare professionals. The platform identifies trends and patterns in engagements, empowering managers with actionable insights. It offers dynamic segmentation and targeting to optimize commercial resources.

Key facts about ODAIA

Founded Year: 2018
Location: Toronto (Canada)
Stage: Series B
Total Funding till date: $44.5M
Employee Count: 108 as on Aug 31, 2026
Investors: Inovia Capital, Threshold and 18 Others
Latest Funding Round: Series B, May 01, 2023, $*****
Highlight: Editors' Pick

2. Deep Genomics

AI-powered platform for RNA biology to accelerate genetic therapy discovery. It focuses on untangling complex RNA data to identify novel targets and therapeutic candidates for genetic conditions. Its offers proprietary AI platform including the flagship model BigRNA that uses machine learning to analyze vast RNA biology data, identify therapeutic targets, and evaluate potential therapeutic candidates efficiently than traditional approaches. The technology helps accelerate early stages of drug discovery and design of RNA-based therapies.

Key facts about Deep Genomics

Founded Year: 2014
Location: Toronto (Canada)
Stage: Series C
Total Funding till date: $238M
Employee Count: 110 as on Sep 30, 2026
Investors: Fidelity Investments, Deep Learning and 16 Others
Latest Funding Round: Series C, Jul 28, 2021, $*****
Highlight: Editors' Pick

3. Quantum Bridge Technologies

Provider of quantum computing technology for communication applications. It designs and develops quantum key infrastructure systems that integrate with existing symmetric encryption modules. Its product portfolio includes a QKI gateway for protecting local area networks, a small-sized QKI gateway to protect small offices, and operators for key distribution systems. It has applications in the government, defence, critical infrastructure, telecommunication, and cybersecurity sectors.

Key facts about Quantum Bridge Technologies

Founded Year: 2019
Location: Toronto (Canada)
Stage: Series A
Total Funding till date: $8M
Employee Count: 29 as on Aug 31, 2026
Investors: Hewlett Packard Enterprise, Juniper Networks and 9 Others
Latest Funding Round: Series A, May 20, 2026, $*****
Highlight: Editors' Pick

4. University of Toronto

Key facts about University of Toronto

Founded Year: 1827
Location: Toronto (Canada)
Annual Revenue: €0 - €1M as on Dec 31, 2023
Stage: Funding Raised
Employee Count: 10 - 49 as on Mar 01, 2026
Investors: Military Health, Europa and 4 Others
Latest Funding Round: Grant (prize money), Mar 12, 2025, $*****

5. Hypercare

Hypercare offers a mobile app and web platform providing care-coordination tools for medical professionals. The tool provided by the company assists in communicating among team members about patient care and delegate tasks within their team. The application enables doctors to send each other priority texts which allow them to gauge its importance and prioritize. Users can create and maintain schedules that can be shared on the platform for access to everyone. Tracking the team-mate's progress and the digital task can be done on the platform. The company provides tools for connecting with patients, other clinics, and allows the sharing of medical pictures and videos on the platform. The pricing of the tool is categorized as Standard plans, Plus plans, and Enterprise plan.

Key facts about Hypercare

Founded Year: 2016
Location: Toronto (Canada)
Stage: Seed
Employee Count: 42 as on Sep 30, 2026
Investors: McNamara Family Investments, Ramen Ventures and 5 Others
Latest Funding Round: Seed, 2016, $*****

View the full list of portfolio companies

UTEST has invested in 112 companies over the last 14 years, with an average of 1 new investment annually in the last 10 years. As of Mar 2026, it has made 1 investment in this year. Its most recent first time investment was in YScope and most recent follow-on round was in Whirlscape.

Here are UTEST's Year-on-Year Investment Trends:

Year	No. of Investments
Year	1^st Round	Follow-on	Total
2026 (YTD)	1	0	1
2025	0	0	0
2024	0	0	0
2023	0	0	0
2022	1	0	1
2021	0	0	0
2020	0	0	0
2019	2	0	2
2018	4	0	4
2017	2	0	2

View all investments by UTEST

UTEST has made 27 investments in Seed stage with an average round size of $186K, 6 investments in Grant (prize money) stage, 2 investments in Series A stage with an average round size of $3.9M and 1 investment in Unattributed stage.

Here are UTEST's investments by stage:

Stage of entry	No. of Investments
Seed	27
Grant (prize money)	6
Series A	2
Unattributed	1

Note: We have considered here, only first round of investments

View all investments by UTEST

UTEST has a diverse portfolio, with companies operating in the Enterprise Applications, HealthTech, Life Sciences, High Tech and Consumer. Notably, it has invested in 75 Tech companies, 68 Enterprise (B2B) companies, 44 Software companies and at least 15 companies focusing on Consumer (B2C).

Here are UTEST's investments by sector:

Sector	No. of Investments
Enterprise Applications	13
HealthTech	11
Life Sciences	8
High Tech	5
Consumer	3
Others	17

Note: We have considered here, only first round of investments

View all investments by UTEST

UTEST has made most investments in Canada (31), followed by United States where it has made 3 investments.

Here are UTEST's investments by geography:

Country	No. of Investments
Canada	31
United States	3
Netherlands	1

Note: We have considered here, only first round of investments

View all investments by UTEST

UTEST has made 1 investments in 2026 so far - YScope.

Here are the most recent investments by UTEST:

Filter this list

Date	Company	Location	Round Details	Round Amount	Co-Investors
Mar 18, 2026	YScope	Canada	Series A	9821	Two Small Fish Ventures [+1]
Feb 01, 2022	QurCan Therapeutics	United States	Grant (prize money)	1694	-
2019	CoHealth	Canada	Grant (prize money)	6765	-
2019	Phycus Biotechnology	Canada	Seed	5455	TIAP
Aug 19, 2018	Bridge7	Canada	Grant (prize money)	9005	-

See more recent investments made by UTEST

6 companies from UTEST's portfolio have been acquired. The most recent acquisition was Pendium Health in Jan 2026 by Arya for $*****.

Here are UTEST's portfolio companies that got acquired most recently:

Filter this list

Company	Acquisition Date	First Invested on	First Round of Investment	Round Size
Pendium Health	Jan 28, 2026	-	-	1056
Mutuo Health Solutions	Nov 02, 2025	-	-	1232
LSK Technologies	May 02, 2022	-	-	9688
CoHealth	Oct 28, 2020	2019	Grant (prize money)	2862
LegUp Computing	Oct 21, 2020	-	-	4821

View all acquired companies in UTEST's portfolio

UTEST has a team of 3 members located in Canada. UTEST's team does not sit on the board of any company as of now.

View team details of UTEST

Over the past 14 years, 38 investors have co-invested in UTEST's portfolio companies. This includes funds and angels.

Invested before UTEST: Ontario Centre of Innovation, Europa and 8 others have invested in rounds before UTEST. There are 2 companies where Ontario Centre of Innovation has invested before UTEST and 1 company where Europa has invested before UTEST.
Top Co-investors of UTEST: 4 investors entered a company along with UTEST. These include investors like TIAP (5 companies).
Invested after UTEST: A total of 24 investors have invested in UTEST's portfolio after their investments. Top Investors include Threshold (1 company) and Monograph (1 company).